ESTERO, FLORIDA / ACCESS Newswire / September 3, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) (“Aspire” or the “Company”), developer of a multi-faceted patent-pending drug delivery technology, ...

DOHA/CAIRO (Reuters) - Mediators gave Israel and Hamas a final draft of a deal on Monday to end the war in Gaza, an official briefed on the negotiations said, after a midnight "breakthrough" in talks ...

Mary’s job is done. On Wednesday, the tunnel-boring machine known as Mary, responsible for digging the two new tunnels for the Hampton Roads Bridge-Tunnel expansion, completed the second and final leg ...

Judge dismisses Columbia University faculty lawsuit over Trump funding cuts, demands A federal judge dismissed a lawsuit against the Trump administration by two labor unions for Columbia University ...

North Hunterdon made a breakthrough at Saturday’s Hunterdon/Warren/Sussex wrestling tournament. Just not THE breakthrough. The Lions put a tourney-high six wrestlers – sophomore Cayden Wadle (106), ...

Aspire’s sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosing TxB2 is a biomarker indicating aspirin’s effect on platelet ...